As the biotech industry rebounds from recent challenges, a favorable regulatory environment and groundbreaking scientific advancements are creating investment opportunities, particularly in companies with...
The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.11%. US stocks this morning...
Corbus Pharmaceuticals: Q1 Earnings Snapshot
Corbus Pharmaceuticals: Q4 Earnings Snapshot
Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m
Corbus Pharmaceuticals: Q3 Earnings Snapshot
/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that an...
Corbus Pharmaceuticals: Q2 Earnings Snapshot
/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today provided a corporate...
/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that Yuval...